cigna glp-1 program requirements glp 1 4 employer strategies for sustainable coverage Cigna dropping all GLP-1 coverage

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

We discuss the translational value of pathophysiological and therapeutic evidence linking BA homeostasis to gut inflammation in IBD.

Nestl is rolling out Vital, a nutrient-dense protein shake line aimed at aging consumers and the GLP-1 era.

GLP-1 receptor agonists have strong clinical backing for weight loss, but HCG combinations remain unproven

This altered revenue composition has clearly indicated that share of insulin would continue to shrink not only in Novos topline in future but also in the overall pie of the diabetes market around the globe